Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia

Effect of body mass index on the outcome of children with acute myeloid leukemia

(2012) Hiroto Inaba et al.   CANCER

Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia

(2012) B. C. Medeiros et al.   HAEMATOLOGICA

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

(2012) Jennifer J. Griggs et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased Body Mass Index Is Associated With Improved Survival in United States Veterans With Diffuse Large B-Cell Lymphoma

(2012) Kenneth R. Carson et al.   JOURNAL OF CLINICAL ONCOLOGY

Is obesity a prognostic factor for acute myeloid leukemia outcome?

(2011) Hun Ju Lee et al.   ANNALS OF HEMATOLOGY

Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

(2011) Roland B. Walter et al.   JOURNAL OF CLINICAL ONCOLOGY

Metformin as an antitumor agent in cancer prevention and treatment

(2011) Donghui LI   Journal of Diabetes

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myelogenous Leukemia (AML) in Adults

(2010) Willis H. Navarro et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Childhood Obesity and Outcomes after Bone Marrow Transplantation for Patients with Severe Aplastic Anemia

(2010) Collin C. Barker et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

(2010) A. S. Green et al.   BLOOD

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

(2010) D. Grimwade et al.   BLOOD

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

(2010) Utz Krug et al.   LANCET

Obesity and the Risk for a Hematological Malignancy: Leukemia, Lymphoma, or Myeloma

(2010) M. A. Lichtman   ONCOLOGIST

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

(2009) N. Chapuis et al.   HAEMATOLOGICA

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

(2009) Bob Löwenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

(2008) G. Juliusson et al.   BLOOD

Dosing chemotherapy in obese patients: Actual versus assigned body surface area (BSA)

(2008) Rodney J. Hunter et al.   CANCER TREATMENT REVIEWS

Overweight, obesity and risk of haematological malignancies: A cohort study of Swedish and Finnish twins

(2008) Karin C. Söderberg et al.   EUROPEAN JOURNAL OF CANCER

Effect of BMI on Primary Treatment of Prostate Cancer

(2008) Benjamin J. Davies et al.   UROLOGY